Effect of autologous platelet-rich plasma in the promotion of healing of chronic ulcers

Mohamed M. Raslan; Nader M. Milad; Ahmed Abd AlAziz

doi:10.18203/2349-2902.isj20175484

Authors

Mohamed M. Raslan Department of General Surgery, Cairo University, Egypt
Nader M. Milad Department of General Surgery, Cairo University, Egypt
Ahmed Abd AlAziz Department of General Surgery, Cairo University, Egypt

DOI:

https://doi.org/10.18203/2349-2902.isj20175484

Keywords:

Autologous platelet rich plasma, Chronic ulcers, Healing, PRP

Abstract

Background: Chronic ulcers are a big health problem worldwide. Having a great impact at personal, social and professional levels. The use of autologous Platelet Rich Plasma (PRP) is a major advance in the treatment of these ulcers as an easy and cost-effective method. Platelets provide numerous growth factors enhancing tissue healing. The aim of this study was to evaluate the safety and efficacy of autologous platelet-rich plasma as a treatment of chronic non-healing ulcers.

Methods: Autologous PRP was prepared from whole blood by centrifugation and activated by 10% calcium chloride. Twenty-Four (24) patients with non-healing ulcers of different etiologies, whom they met our inclusion criteria, were treated with PRP injected every two weeks locally into their wounds until healing. The ulcer dimensions were measured every week. The follow-up period was 12 weeks after healing.

Results: The mean age of the study population 41±21 years. Complete healing was achieved in all patients. The mean rate of healing (average decrease in ulcer dimensions) was 0.48 cm/week. The rate of healing was greater at the week following injection. The mean time for healing was 6.11 weeks.

Conclusions: Author witnessed the useful effects of PRP application on enhancing wound healing. The results from our case series showed that PRP is a safe and effective treatment for the promotion of healing chronic ulcers. Further research and controlled, randomized prospective clinical trials on larger patient population are important to validate our results.

Metrics

Metrics Loading ...

References

San Sebastian KM, Lobato I, Hernández I, Burgos-Alonso N, Gomez-Fernandez MC, López JL, et al. Efficacy and safety of autologous platelet rich plasma for the treatment of vascular ulcers in primary care: Phase III study. BMC Fam Pract. 2014;15:211.

Greer N, Foman NA, MacDonald R, Dorrian J, Fitzgerald P, Rutks I, et al. Advanced wound care therapies for nonhealing diabetic, venous, and arterial ulcers a systematic review. Annals of Internal Medicine. 2013;159(8):532-42.

Martinez-Zapata MJ, Marti-Carvajal AJ, Sola I, Exposito JA, Bolíbar I, Rodriguez L, Garcia J. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev. 2012;10.

Aminian B, Shams M, Karim-Aghaee B, Soveyd M, Omrani GR. The role of the autologous platelet-derived growth factor in the management of decubitus ulcer. Arch Iranian Med. 1999;2:98-101.

Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21(1):71-81.

Driver VR, Hanft J, Fylling CP, Beriou JM. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Management. 2006;52(6):68.

Damir A. Recent advances in the management of chronic non-healing diabetic foot ulcers. JIMSA. 2011;24(4):219-23.

Brandt E, Ludwig A, Petersen F, Flad HD. Platelet-derived CXC chemokines: old players in new games. Immunol Rev. 2000;177:204-16.

English D, Garcia JG, Brindley DN. Platelet-released phospholipids link hemostasis and angiogenesis. Cardiovasc Res. 2001;49:588-99.

Snyder EL, Calhoun BC. Topical platelet growth factor therapy: of lotions and potions. Transfusion. 2001;41:1186-9.

Obolenskiy VN, Ermolova DA, Laberko LA, Semenova TV. Efficacy of platelet-rich plasma for the treatment of chronic wounds. EWMA J. 2014;14(1).

Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regen Med. 2013;8(5):645-58.

Sommeling CE, Heyneman A, Hoeksema H, et al. The use of platelet-rich plasma in plastic surgery: a systematic review. J Plast Reconstr Aesthet Surg. 2013;66:301-11.

Suresh DH, Suryanarayan S, Sarvajnamurthy S, Puvvadi S. Treatment of a non-healing diabetic foot ulcer with platelet-rich plasma. J Cutaneous Aesthetic Surg. 2014 Oct;7(4):229.

Suryanarayan S, Budamakuntla L, Khadri SI, Sarvajnamurthy S. Efficacy of autologous platelet-rich plasma in the treatment of chronic nonhealing leg ulcers. Plastic Aesthetic Res. 2014;1(2):65-9.

Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann surg. 1986;204(3):322.

Lyras DN, Kazakos K, Verettas D, Polychronidis A, Tryfonidis M, Botaitis S, et al. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int. 2009;30(11):1101-6.

Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, Lee Y. Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Ann Dermato. 2011;23(4):424-31.

Roy S, Driggs J, Elgharably H, Biswas S, Findley M, Khanna S, et al. Platelet‐rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Wou Rep Reg. 2011;19(6):753-66.

Serra R, Buffone G, Dominijanni A, Molinari V, Montemurro R, de Franciscis S. Application of platelet‐rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients. Int Wo J. 2013;10(5):612-5.

Saad Setta H, Elshahat A, Elsherbiny K, Massoud K, Safe I. Platelet‐rich plasma versus platelet‐poor plasma in the management of chronic diabetic foot ulcers: a comparative study. Int Wo J. 2011;8(3):307-12.

Shan GQ, Zhang YN, Ma J, Li YH, Zuo DM, Qiu JL, et al. Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes. Int J Low Ext Wo. 2013;12(1):22-9.

Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco Í, do Amaral RJ, Granjeiro JM, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Research Therapy. 2013;4(3):67.

Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G, Andia I. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biol Med Materials Research Part B: Applied Biomaterials. 2008;84(2):415-21.

Lacci MK, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83(1):1-9.